Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
Clinical trial NCT01870778 · COMPLETED
Trial details
- NCT number
- NCT01870778
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-02
- Primary completion
- 2017-01-23
- Enrollment
- 6600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.